Trader consensus favors "No" at 65% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the complete absence of any such designations currently, per the official CDC page last reviewed April 16, 2026. Recent Level 2 notices for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10) reflect heightened but not critical transmission risks to U.S. travelers, falling short of Level 3 criteria for severe, ongoing outbreaks. H5N1 avian influenza surveillance confirms sporadic human cases globally—26 U.S. infections through early 2025—with no evidence of sustained human-to-human spread or elevated public health risk. The 2025-2026 influenza season's 155 pediatric deaths signal intensity but waning activity post-peak. Upcoming CDC surveillance reports and WHO assessments could shift dynamics if novel threats emerge.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоCDC выпустит предупреждение 3-го уровня до 31 декабря?
CDC выпустит предупреждение 3-го уровня до 31 декабря?
Да
$115,732 Объем
$115,732 Объем
Да
$115,732 Объем
$115,732 Объем
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Открытие рынка: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus favors "No" at 65% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the complete absence of any such designations currently, per the official CDC page last reviewed April 16, 2026. Recent Level 2 notices for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte (March 10) reflect heightened but not critical transmission risks to U.S. travelers, falling short of Level 3 criteria for severe, ongoing outbreaks. H5N1 avian influenza surveillance confirms sporadic human cases globally—26 U.S. infections through early 2025—with no evidence of sustained human-to-human spread or elevated public health risk. The 2025-2026 influenza season's 155 pediatric deaths signal intensity but waning activity post-peak. Upcoming CDC surveillance reports and WHO assessments could shift dynamics if novel threats emerge.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы